Hormonal Therapy for Prostate Cancer May Raise Diabetes Risk

Share this content:

Men receiving androgen deprivation therapy for prostate cancer may be at higher risk of developing diabetes and metabolic syndrome. John Schieszer has the story in today's Medical Minute.
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters